SCHEMBL177192

SCHEMBL177192

CC(O)Cc1cccn2cnnc12

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 1/20 0.34
PDE1B Q01064 1/20 0.34
PDE1C Q14123 1/20 0.34
GABRA1 P14867 1/20 0.30
GABRB2 P47870 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21105599 0.78 NR1I2 (0.40) PDE1APDE1BPDE1C
Hydrochloric Acid SCHEMBL21067209 0.77 NR1I2 (0.39) PDE1APDE1BPDE1C
SCHEMBL4866590 0.72 DHFR (0.44)
SCHEMBL21067154 0.72 PDE1A (0.33) PDE1APDE1BPDE1C
SCHEMBL6269053 0.71 NR1I2 (0.40) PDE1APDE1BPDE1CGABRA1GABRB2
SCHEMBL2789584 0.70 KDM4E (0.34)
SCHEMBL26901801 0.70 TSHR (0.41) PDE1APDE1BPDE1C
SCHEMBL20696788 0.69 TOP2A (0.36) PDE1APDE1BPDE1CGABRA1
SCHEMBL25468685 0.68 PDE1A (0.32) PDE1APDE1BPDE1C
SCHEMBL21258479 0.67 TOP2A (0.34) PDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611805-A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT Takeda Pharmaceutical Company Limited (JP) 2013-07-10 EP disclosed
WO-2012029991-A1 FUSED TRIAZOLES FOR THE TREATMENT OR PROPHYLAXIS OF MILD COGNITIVE IMPAIRMENT TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-03-08 WO disclosed